key: cord-0755516-smfsmk4x
authors: Fournier, Pierre-Edouard; Colson, Philippe; Levasseur, Anthony; Devaux, Christian A.; Gautret, Philippe; Bedotto, Marielle; Delerce, Jeremy; Brechard, Ludivine; Pinault, Lucile; Lagier, Jean-Christophe; Fenollar, Florence; Raoult, Didier
title: Emergence and outcome of the SARS-CoV-2 “Marseille-4” variant
date: 2021-03-27
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.03.068
sha: 540efb41cacfcc4b20768a9656ae0b094bd3c589
doc_id: 755516
cord_uid: smfsmk4x

Introduction In Marseille, France, following a first SARS-CoV-2 outbreak in March-May 2020, a second epidemic phase occurred from June, involving ten new variants. The Marseille-4 variant caused an epidemic that started in August and is still ongoing. Materials and methods The 1,038 SARS-CoV-2 whole genome sequences obtained in our laboratory by next-generation sequencing with Illumina technology were analyzed using Nextclade and nextstrain/ncov pipelines and IQ-TREE. A Marseille-4-specific qPCR assay was implemented. Demographic and clinical features were compared between patients with Marseille-4 and earlier strains. Results Marseille-4 harbors 13 hallmark mutations. One leads to S477 N substitution in the spike receptor binding domain targeted by current vaccines. Using a specific qPCR, we observed that Marseille-4 caused 12-100% of SARS-CoV-2 infections in Marseille from September 2020, being involved in 2,106 diagnoses. This variant was more frequently associated with hypoxemia than clade 20A strains before May 2020. It caused re-infection in eleven patients SARS-CoV-2-diagnosed with different strains before June 2020, suggesting either short-term protective immunity or lack of cross-immunity. Discussion/conclusion Marseille-4 should be considered as a major SARS-CoV-2 variant. Its sudden appearance points toward an animal reservoir, possibly minks. The protective role of past-exposure and current vaccines against this variant should be evaluated.

The SARS CoV-2 epidemic that started in Wuhan, China, in December 2019, has rapidly spread around the world (https://coronavirus.jhu.edu/map.html). From January 2020, at the Mediterranee Infection institute (IHU) in Marseille, we set up the routine diagnosis of SARS-CoV-2 by PCR (Lagier et al., 2020 , Colson et al., 2020a . The first SARS-CoV-2infected patient was diagnosed at the IHU on 02/27/2020 (Colson et al., 2020c) (https://www.mediterranee-infection.com/covid-19/). Since then, we performed more than 450,000 SARS-CoV-2 PCR tests, 2,000 virus isolations by cell culture, 2,000 whole genome sequencings and took care of 14,000 positive cases. In Europe, the SARS-CoV-2 circulation was characterized by two major episodes. The first one, herein referred to as phase 1, started in February and almost ended in May (Colson et al., 2021a) . However, at the end of June a second phase (phase 2) suddenly occurred, exhibiting an atypical epidemic curve which led us to suspect that the two episodes were caused by distinct viral variants. Hence, we performed whole genome sequencing of SARS-CoV-2 strains over time to characterize their genetic diversity. This enabled us to identify 10 distinct genomic patterns that successively or concomitantly spread in the Marseille area (Colson et al., 2021c; Fournier et al., 2021) . Of these, two variants were identified at high frequency in the population of individuals diagnosed at the IHU. The Marseille-1 variant caused mild infections in younger patients and predominated from the end of June to the end of July 2020 . We accumulated evidence indicating that this variant originated in Africa and was brought to J o u r n a l P r e -p r o o f Marseille by ferry boat travelers and sailors from North Africa. In France, it did not spread outside Marseille and vanished rapidly. On July 29 th , 2020, a new variant was identified and named Marseille-4 (Figures 1, 2) . We named to study the virological, clinical and epidemiological characteristics of this variant.

Viral genomes were obtained from nasopharyngeal swab fluid using next-generation sequencing (NGS) and the Illumina Nextera XT paired-end strategy on a MiSeq instrument (Illumina Inc., San Diego, CA, USA), as previously described . Genome consensus sequences were assembled by mapping on the SARS-CoV-2 genome GenBank accession no. NC_045512.2 (Wuhan-Hu-1 isolate) using the CLC Genomics workbench v.7, with as thresholds 80% for nucleotide sequence coverage and 90% for nucleotide similarity.

SARS-CoV-2 sequences obtained in our institute have been submitted to the GISAID database (www.gisaid.org).

The 1,038 SARS-CoV-2 whole genome sequences obtained in our laboratory were analyzed using the Nextclade tool (https://clades.nextstrain.org/) (Hadfield et al., 2018) and an in-house script written in Python. Viral clades were defined on the basis of at least five available genomes sharing the same pattern of mutations. Phylogenetic trees were reconstructed by using the nextstrain/ncov tool (https://github.com/nextstrain/ncov) and visualized with the Auspice software (https://docs.nextstrain.org/projects/auspice/en/stable/).

In addition, the SARS-CoV-2 genomes obtained in our laboratory were integrated in another phylogenetic analysis together with sequences from the GISAID database (www.gisaid.org) that were recovered from humans and minks. All these genomes were aligned using MAFFT J o u r n a l P r e -p r o o f v.7 (Katoh et al., 2013) . Then, phylogeny reconstruction was performed using the IQ-TREE software with the GTR Model and 1,000 ultrafast bootstrap repetitions (www.iqtree.org) (Minh et al., 2020) , and the tree was visualized with the iTOL (Interactive Tree Of Life) software (https://itol.embl.de/) (Letunic et al., 2016) .

A qPCR system was designed that targets the nsp4 gene at nucleotide positions 9,460-9,543 in reference to genome GenBank accession no. NC_045512.2 (Wuhan-Hu-1 isolate).

The primers and probe are described in Supplementary Table S1 . This qPCR was run on a LC480 thermocycler (Roche Diagnostics, Mannheim, Germany). The reaction mixture contained 5 μL of 4X TaqMan Fast Virus 1-Step Master Mix (Thermo Fisher Scientific, Grand Island, NY, USA), 0.5 μL of forward primer (10 pmol/µL), 0.5 μL of reverse primer (10 pmol/µL), 0.4 μL of probe (10 pmol/µL), and 8.6 μL of water, and it was completed with 5 μL of extracted viral RNA. PCR conditions were as follows: a reverse transcription step for 10 min at 50°C, then 20 sec at 95°C followed by 40 cycles comprising a denaturation step at 95°C for 15 sec and a hybridization and elongation step at 60°C for 60 sec. (Lan et al., 2020) . It is a major target of neutralizing antibodies (Barnes et al., 2020) and the current vaccines (Dai et al., 2020) (Figure 4 ). The S477N substitution has been reported to be associated with broad resistance to monoclonal neutralizing antibodies (Liu et al., ) . These data could explain the lack of resistance to infection by this Marseille-4 variant among people previously infected with different strains that circulated earlier, during the first phase of the 2020 pandemic. This substitution lies between substitutions observed in viruses infecting humans and others seen in viruses infecting minks ( Figure 4) (Garry, 2021) . It adds to the D614G substitution that was reported to increase the stability of spike trimers and confers greater affinity for ACE2 (Korber et al., 2020) . It is worthy to note that the first genome available in the GISAID database (EPI_ISL_7079562020-03-24) that originates from Germany on March 24 th 2020, J o u r n a l P r e -p r o o f did not harbor this S477N substitution, which may explain that it did not apparently spread further. Other critical mutations may be substitution Q57H in ORF3a, a viroporin that forms ion channels and was reported as required for viral replication, virulence and release, and is also predicted to be a pro-apoptotic protein (Bianchi et al., 2021 , Law et al., 2005 , and substitutions A176S in the RdRp and K1141R and E1184D in the NTPase/helicase.

The origin of the Marseille-4 variant is currently unknown. It emerged abruptly with its block of specific mutations, with no known intermediate form, while the SARS-CoV-2 epidemic had almost ended in France and Europe (Figure 1, Figure 3 ). This apparently discontinuous evolution of SARS-CoV-2 genomes is abnormal, particularly if we consider that after its first detection this variant had shown a subsequent mutation rate similar to that of other lineages (e.g., mutation in the RdRp did not alter the polymerase fidelity). Although we cannot exclude that the missing intermediate exists but has not been sequenced so far from COVID-19 patients, this could also suggest that there is an overlooked reservoir in which the virus was submitted to a selection pressure that favored a particular increase in mutation accumulation. Interestingly, among the 10,516 sequences from the Marseille-4 variant in the GISAID database (on January 24 th , 2021), the 272 genomes from our laboratory had close relatives with those originating from Northern Europe, mostly Denmark (3,366), the UK (2,652) and Switzerland (1,147) (Supplementary Figure S1) . A phylogenetic tree was constructed that included genomes from mink and human SARS-CoV-2 strains. Mink strains were divided into five and six main groups, for the samples from the Netherlands and Denmark, respectively ( Figure 5 ). We observed a common phylogenetic node between mink strains, the Marseille-4, Marseille-5, Marseille-6 variants and the 20H/501Y.V2 variant from

England. This node pointed to the above-described common mutation, Q57H in ORF3a. The rapid emergence of the Marseille-4 variant during summer 2020, after the end of the first J o u r n a l P r e -p r o o f epidemic phase, may point toward an animal reservoir. Mink farms were identified as reservoirs and sources of SARS-CoV-2 mutants in the Netherlands in April (Oude Munnink et al., 2021) , and in Denmark in June 2020 (Hammer et al., 2020) . In France, one of the four mink farms was infected and animals were culled. SARS-CoV-2 is an epizootic agent that caused an outbreak in humans before being transferred to mink in which it spread rapidly through densely caged animals and subsequently became a source for human infection. To date, more than 800 human infections from minks have been reported (Oude Munnink et al., 2021) . One hypothesis could be that a human SARS-CoV-2 from infected caregivers infected mink, then the frequency of viral mutations changed in the mink due to a different host selection pressure, and this mink-adapted virus (with multiple mutations) became a new viral source to infect humans. The genome obtained from a German patient sampled on March 24 th (EPI_ISL_7079562020-03-24) is atypical as it is devoid of the S477N substitution, one of the Marseille-4 hallmark mutations, but harbors more mutations (n= 31) than the other Marseille-4 strains, including in Nsp2, Nsp3, S and N proteins, and in ORF1b, particularly the Nsp14 exonuclease, which has a proofreading activity (Shannon et al., 2020) . The evolutionary relationships of this genome with other Marseille-4 genomes warrants a further investigation with the availability of other genomes obtained from samples collected during the same period.

Compared to the clade 20A strains that predominated during phase 1 between March and May 2020, the Marseille-4 variant was associated with a lower frequency of cough, rhinitis and olfactory and gustatory disorders (Table 2) . By contrast, hypoxemia was more frequent in patients infected with Marseille-4 variant. It was reported that differences observed in COVID-19 severity may in part be associated with the dysfunction of cellular J o u r n a l P r e -p r o o f immune responses to SARS-CoV-2 and/or a weakness of neutralizing humoral response (Moderbacher et al., 2020) . We diagnosed two successive COVID-19 infections, separated by more than 4 months, in 11 patients. The first infection was diagnosed before June 2020 when Marseille-4 was circulating in Marseille (Colson et al., 2020b; Brouqui et al., 2021) , and we obtained genomic or qPCR (1 and 10 patients, respectively) confirmation that the second episode was caused by the Marseille-4 variant. This suggests either a short protective immunity (only a few weeks or months) as previously observed with seasonal coronaviruses (Edridge et al., 2020) , or a lack of cross-immunity between different SARS-CoV-2 variants, allowing Marseille-4 to evade immune protection elicited by another earlier variant. This may be related to the S477N mutation which could change the affinity of RBD for ACE2 and decrease the sensitivity of the variant virus to anti-RBD-specific neutralizing antibodies (Andreano et al., 2020) .

The recent evolution of the SARS-CoV-2 epidemics reflects the generation of new variants in different ecosystems that spread with globalization and replaced the original variants issued from Wuhan. Some can be associated with different clinical features as for the case of the Marseille-4 variant. The ecosystems allowing this selection may consist of human groups isolated for a while, or animal reservoirs such as minks in large farms. Large concentrations of farmed minks were infected by human SARS-CoV-2 (Oude Munnink et al., 2020) . Under these conditions, sub-speciation may occur (Darwin, 1859) . The re-connection of isolated ecosystems (either countries and/or farmed animals) where different variants had developed generated new outbreaks in countries that were exposed to incoming populations such as travelers. Several reasons lead us to believe that minks were the source of the Marseille-4 variant. First, this variant carries a new set of several mutations which seems to have appeared suddenly based on the analysis of all the genomes available worldwide, and not gradually. This suggests that this brutal genome evolution had been overlooked. Secondly, there was no SARS-CoV-2 epidemic in France at the time of the emergence of this variant, except in a region near the city of Laval (Mayenne, Western France) located between the most dense area in wild minks (Brittany) and a mink farm (Eure-et-Loire) where 30% of minks were proved to be SARS-CoV-2-positive by qPCR and 97% had antibodies against the virus.

As a consequence, the entire farm mink population was slaughtered (https://www.plateformeesa.fr/article/covid-19-et-animaux-mise-a-jour-au-05-01-2021; Fenollar et al., 2021) .

Progressively, this SARS-CoV-2 epidemic spread in France during the summer, and we observed the first cases of Marseille-4 infections in Marseille when French tourists arrived in our region. For unknown reasons, the sequence of the virus of the farm minks infected mid-November is not yet available.

Overall, we believe that the segregation of viral strains in isolated geographical areas and in animal reservoirs may contribute to explain the differences observed among epidemic curves around the world. This would help to understand the mechanism of the second episode that developed in Marseille, initially caused by an African variant that disappeared , and then by emerging new variants linked to different areas of Europe, including those hosting huge mink farms. Finally, the role of the treatment of COVID-19 by remdesivir or hyperimmune plasma (Choi et al., 2020 , Kemp et al., 2020 Full-length genome sequences obtained in our study were compared to those available in the GISAID database (https://www.gisaid.org/). Phylogenetic trees were reconstructed and visualized by using the Nextstrain pipeline (https://github.com/nextstrain/ncov/) (Hadfield et al., 2018) . a. Time-scale phylogenetic tree. b. Phylogenetic tree based on mutational events. The structure was predicted using the Phyre2 web portal (http://www.sbg.bio.ic.ac.uk/~phyre2/html/page.cgi?id=index) (Kelley et al., 2015) and J o u r n a l P r e -p r o o f visualized using the Pymol tool v.1.8 (https://pymol.org/2/) (Janson et al., 2020) . Amino acids where a substitution was observed in humans are colored in red, where a substitution was observed in minks are colored in yellow, and those where a substitution was observed in humans and minks are colored in orange.

A total of 744 genomes of SARS-CoV2 were integrated in a phylogenetic analysis. All genomes were aligned using MAFFT version 7 (Katoh et al., 2013) . Phylogenetic tree was reconstructed by using IQ-TREE with the GTR model with 1,000 ultrafast bootstrap repetitions (Minh et al., 2020) , and visualized with iTOL (Interactive Tree Of Life, (https:// 

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

SARS-Cov-2 ORF3a: Mutability and function

COVID-19 reinfection

Persistence and evolution of SARS-CoV-2 in an immunocompromised Host

Temporal and age distributions of SARS-CoV-2 and other coronaviruses

Evidence of SARS-CoV-2 re-infection with a different genotype

Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2

Dramatic increase in the SARS-CoV-2 mutation rate and low mortality rate during the second epidemic in summer in Marseille. IHU pre-prints 2020c

Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa

Viral targets for vaccines against COVID-19

On the origin of species

Seasonal coronavirus protective immunity is short-lasting

SARS-CoV-2, and the human-animal interface

Genome sequence analysis enabled deciphering the atypical evolution of COVID-19 epidemics in Marseille, France. IHU pre-prints 2021

Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage

Nextstrain: realtime tracking of pathogen evolution

SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

PyMod 3: a complete suite for structural bioinformatics in PyMOL

MAFFT multiple sequence alignment software version 7: improvements in performance and usability

The Phyre2 web portal for protein modeling, prediction and analysis

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

Structure of the SARS-CoV-2 spike receptorbinding domain bound to the ACE2 receptor

The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells

Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees

Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. C  T   CCT>C  TT  314  P314L   10  28   1  2 C T T T T T T T T T T T T T T T T   15766   nsp1  2b  G  T   GTG>T  TG  767  V767L   26  8   1  2 G G G G G T T T T T T T T T T T T   16889   nsp1  3  A  G   AAA>A  GA  218  K218R 26 9 T   25563   ORF  3a  G  T   CAG>C  AT  57  Q57H   65  7   1  2 G G T T T T T T T T T T T T T T T   25710   ORF  3a  C  T   CTC>C  TT  106  L   27  2   1  2 C C C C C T T T T T T T T T T T T   26442  E  T  C   AAT>A  AC  66  N  6 1 T T T T T T T T T T T C T T T T T 26 3